ID24903A - Komposisi-komposisi, kit, dan metode untuk menghambat gangguan neurovaskular serebral dan sakit kepala muskular - Google Patents

Komposisi-komposisi, kit, dan metode untuk menghambat gangguan neurovaskular serebral dan sakit kepala muskular

Info

Publication number
ID24903A
ID24903A IDW20000123D ID20000123D ID24903A ID 24903 A ID24903 A ID 24903A ID W20000123 D IDW20000123 D ID W20000123D ID 20000123 D ID20000123 D ID 20000123D ID 24903 A ID24903 A ID 24903A
Authority
ID
Indonesia
Prior art keywords
cultural
kits
compositions
remove
methods
Prior art date
Application number
IDW20000123D
Other languages
English (en)
Indonesian (id)
Inventor
Bruce H Levin
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ID24903A publication Critical patent/ID24903A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW20000123D 1997-07-21 1998-07-17 Komposisi-komposisi, kit, dan metode untuk menghambat gangguan neurovaskular serebral dan sakit kepala muskular ID24903A (id)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89719297A 1997-07-21 1997-07-21
US7284598P 1998-01-28 1998-01-28
US8455998P 1998-05-06 1998-05-06

Publications (1)

Publication Number Publication Date
ID24903A true ID24903A (id) 2000-08-31

Family

ID=27372174

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000123D ID24903A (id) 1997-07-21 1998-07-17 Komposisi-komposisi, kit, dan metode untuk menghambat gangguan neurovaskular serebral dan sakit kepala muskular

Country Status (20)

Country Link
EP (1) EP0999839B1 (de)
JP (1) JP4521117B2 (de)
KR (1) KR20010022041A (de)
CN (1) CN1267219A (de)
AR (1) AR013240A1 (de)
AT (1) ATE269702T1 (de)
AU (1) AU8574398A (de)
BR (1) BR9810773A (de)
CA (1) CA2297097C (de)
DE (1) DE69824730T2 (de)
EE (1) EE200000050A (de)
HU (1) HUP0003953A3 (de)
ID (1) ID24903A (de)
IL (2) IL134087A0 (de)
IS (1) IS5349A (de)
NO (1) NO20000293L (de)
PL (1) PL338176A1 (de)
SK (1) SK187899A3 (de)
TR (1) TR200000149T2 (de)
WO (1) WO1999003473A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
JP4632499B2 (ja) * 1999-08-26 2011-02-16 武田薬品工業株式会社 鼻粘膜付着マトリックス
AU2100901A (en) * 1999-12-15 2001-06-25 Bruce H. Levin Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
GB9930083D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
US7117033B2 (en) 2000-05-08 2006-10-03 Brainsgate, Ltd. Stimulation for acute conditions
AU5662001A (en) 2000-05-08 2001-11-20 Brainsgate Ltd. Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the bbb and cerebral blood flow
US7640062B2 (en) 2000-05-08 2009-12-29 Brainsgate Ltd. Methods and systems for management of alzheimer's disease
US7146209B2 (en) 2000-05-08 2006-12-05 Brainsgate, Ltd. Stimulation for treating eye pathologies
US6853858B2 (en) 2000-05-08 2005-02-08 Brainsgate, Ltd. Administration of anti-inflammatory drugs into the central nervous system
WO2004043218A2 (en) 2002-11-14 2004-05-27 Brainsgate Ltd. Surgical tools and techniques for stimulation
US7561919B2 (en) 2002-11-14 2009-07-14 Brainsgate Ltd. SPG stimulation via the greater palatine canal
WO2005062829A2 (en) 2003-12-19 2005-07-14 Advanced Bionics Corporation Skull-mounted electrical stimulation system and method for treating patients
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
US7592371B2 (en) 2004-08-18 2009-09-22 Medrx Co., Ltd. External preparation
AU2009274137B2 (en) * 2008-07-21 2013-10-31 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
DE102008037682A1 (de) 2008-08-14 2010-04-08 Strackharn, Klaus, Dr.med. Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen
US9889109B2 (en) 2012-09-28 2018-02-13 St. Renatus, Llc Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
CN103432378A (zh) * 2013-08-15 2013-12-11 吕清华 一种治疗神经血管性头痛的中药
US9675796B2 (en) 2013-11-10 2017-06-13 Brainsgate Ltd. Implant and delivery system for neural stimulator
US10271907B2 (en) 2015-05-13 2019-04-30 Brainsgate Ltd. Implant and delivery system for neural stimulator
CN113573705A (zh) * 2018-12-19 2021-10-29 诺迪克控股公司 鼻内利多卡因的治疗组合物
WO2020152212A1 (en) * 2019-01-22 2020-07-30 Icm (Institut Du Cerveau Et De La Moelle Épinière) Local anesthetic for the treatment of neurological symptoms resulting from brain dysfunctions
GB2628149A (en) * 2023-03-16 2024-09-18 Lee Nathaniel Wurie Nasal spray for performing sphenopalatine ganglion block

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
DE19524691A1 (de) * 1995-07-06 1997-01-09 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen
DE19526019A1 (de) * 1995-07-17 1997-01-23 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Kopfschmerzen
BE1009851A3 (fr) * 1996-01-11 1997-10-07 Thiebauld Charles Marie Composition pharmaceutique pour le traitement des cephalees et son utilisation.
GB2315673A (en) * 1996-08-01 1998-02-11 Merck & Co Inc Treatment of migraine
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use

Also Published As

Publication number Publication date
AU8574398A (en) 1999-02-10
HUP0003953A3 (en) 2002-02-28
DE69824730D1 (de) 2004-07-29
BR9810773A (pt) 2000-09-19
CA2297097C (en) 2009-04-07
KR20010022041A (ko) 2001-03-15
PL338176A1 (en) 2000-10-09
DE69824730T2 (de) 2005-07-14
NO20000293L (no) 2000-03-20
TR200000149T2 (tr) 2000-05-22
IL134087A (en) 2006-10-31
CA2297097A1 (en) 1999-01-28
EE200000050A (et) 2000-10-16
EP0999839B1 (de) 2004-06-23
EP0999839A1 (de) 2000-05-17
JP4521117B2 (ja) 2010-08-11
CN1267219A (zh) 2000-09-20
HUP0003953A1 (hu) 2002-01-28
NO20000293D0 (no) 2000-01-20
JP2001513483A (ja) 2001-09-04
SK187899A3 (en) 2000-12-11
IS5349A (is) 2000-01-18
WO1999003473A1 (en) 1999-01-28
ATE269702T1 (de) 2004-07-15
IL134087A0 (en) 2001-04-30
AR013240A1 (es) 2000-12-13

Similar Documents

Publication Publication Date Title
ID24903A (id) Komposisi-komposisi, kit, dan metode untuk menghambat gangguan neurovaskular serebral dan sakit kepala muskular
DE69819033D1 (de) Zusammensetzungen zum kleben von fluorkunststoffen
DE69941559D1 (de) Enzymgemisch
ID19662A (id) Komposisi hidrokarbon mengandung fluorin
EP1028720A4 (de) Methoden, zusammenstellungen und sets zur steigerung des weiblichen sexualdrangs und der sexuellen empfänglichkeit
ID19830A (id) Peralatan dan metode penguraian isi kode/pengkodean audio yang dapat diskalakan
ID20996A (id) Lembaran penyeka dan metode untuk memproduksinya
AU8909998A (en) Methods and compositions for cloning nucleic acid molecules
ID24610A (id) Radas serta metode untuk mengkristalisasian
ID20268A (id) Landasan ski di dalam ruangan, serta metoda dan pengontrol landasan ski di dalam ruangan
ID20911A (id) Pak rokok serta metode dan peralatan untuk membuat pak rokok tersebut
ID17689A (id) Silika yang diendapkan dalam bentuk amorf
AU2001268232A1 (en) Compositions, methods, and kits relating to resistin-like molecules
DE59808967D1 (de) Mittel zum Reinigen von harten Oberflächen
ID19122A (id) Silika yang diendapkan dalam bentuk amorf
AU2002239739A1 (en) Compositions, methods and kits relating to remodelin
NO985273D0 (no) FremgangsmÕte ved liming, samt anordning derav
FR2767684B1 (fr) Composition demaquillante
NO20005483D0 (no) Ny sammensetning
AU2002237733A1 (en) Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
GB9826899D0 (en) Methods to treat depression and other psychiatric disorders and assays for compounds
IT1290409B1 (it) Attrezzo guidabile da neve
DE59806271D1 (de) Formstein-bausatz
BA96175A (bs) 4-Tia-1-azabiciklo¬3.2.0.¾heptan-3- imino-2-izopropiliden-7-okso analogoni beta-laktama postupci priprave i upotreba
HK1027045A (en) Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches